nach oben

Erschienen in:

01.03.2004 | Regular Paper

Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs

verfasst von: S. Czub, M. Czub, E. Koutsilieri, S. Sopper, F. Villinger, J. G. Müller, C. Stahl-Hennig, P. Riederer, V. ter Meulen, G. Gosztonyi

Erschienen in: Acta Neuropathologica | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Drug abuse and human immunodeficiency virus (HIV) infection seem to cause cumulative damage in the central nervous system (CNS). Elevated extracellular dopamine is thought to be a prime mediator of the reinforcing effects of addictive substances. To investigate the possible role of increased dopamine availability in the pathogenesis of HIV dementia, simian immunodeficiency virus (SIV)-infected monkeys were treated with dopaminergic drugs (selegiline or l-DOPA). Both substances increased intracerebral SIV expression, combined with aggravation of infection-related neuropathology and ultrastructural alterations of dendrites in dopaminergic areas (spongiform polioencephalopathy) in asymptomatic animals. Moreover, this treatment resulted in enhanced TNF-α expression in the brains of SIV-infected animals. These findings indicate a synergistic interaction between dopamine and SIV infection on microglia activation, leading to increased viral replication and production of neurotoxic substances. Our results suggest that increased dopamine availability through dopaminergic medication or addictive substances may potentiate HIV dementia.

Artigas J, Niedobitek F, Grosse G, Heise W, Gosztonyi G (1989) Spongiform encephalopathy in AIDS dementia complex: report of five cases. J Acquir Immune Defic Syndr 2:374–381PubMed

Bell J, Donaldson Y, Lowrie S, McKenzie C, Elton R, Chiswick A, Brettle R, Ironside J, Simmonds P (1996) Influence of risk group, Zidovudine therapy and immunosuppression on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 10:493–499PubMed

Benveniste E, Huneycott B, Shrikant P, Ballestas M (1995) Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behav Immun 9:304–314CrossRefPubMed

Berger JR, Nath A (1997) HIV dementia and the basal ganglia. Intervirology 40:122–131

Budka H, Wiley C, Kleihues P, Artigas J, Asbury A, Cho E, Cornblath D, DalCanto M, DeGirolami U, Dickson D, Epstein L, Esiri M, Giangaspero F, Gosztonyi G, Gray F, Griffin J, Henin D, Iwasaki Y, Janssen R, Johnson R, Lantos P, Lyman W, McArthur J, Nagashima K, Peress N, Petito C, Price R, Rhodes R, Rosenblum M, Said G, Scaravilli F, Sharer L, Vinters H (1991) HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology—Consensus Report. Brain Pathol 1:143–152PubMed

Caine SB (1998) Cocaine abuse: hard knocks for the dopamine hypothesis? Nat Neurosci 1:90–92CrossRefPubMed

Chen G, Tachibana K, Huang DS, Watson RR (1993) Cocaine modulation in vitro of tumor necrosis factor production by macrophages from retrovirally infected mice. Life Sci 52:1641–1647CrossRefPubMed

Czub M, Czub S, Gosztonyi G, Koutsilieri E, Sopper S, Muller JG, Gerlach M, Riederer P, Meulen V ter (1999) Effects of Selegiline in a retroviral rat model for neurodegenerative disease. J NeuroVirol 5:458–464PubMed

Czub S, Muller JG, Czub M, Muller-Hermelink HK (1996) Nature and sequence of simian immunodeficiency virus-induced central nervous system lesions: a kinetic study. Acta Neuropathol 92:487–498CrossRefPubMed

10.

Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, Meulen V ter (2001) Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol 101:85–91PubMed

11.

Davies J, Everall I, Weich S, McLaughlin J, Scaravilli F, Lantos P (1997) HIV-associated brain pathology in the United Kingdom: an epidemiological sstudy. AIDS 11:1145–1150CrossRefPubMed

12.

Demuth M, Czub S, Sauer U, Koutsilieri E, Haaft P, Heeney J, Stahl-Hennig C, Meulen V ter, Sopper S (2000) Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV. J NeuroVirol 6:187–201PubMed

13.

DiChiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278PubMed

14.

Everall I, Luthert P, Lantos P (1993) A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 52:561–566PubMed

15.

Gosztonyi G, Schmidt V, Nickel R, Rothschild M, Camach S, Siegel G, Zill E, Pauli G, Schneider V (1993) Neuropathologic analysis of postmortal brain samples of HIV-seropositive and -seronegative i.v. drug addicts. Forensic Sci Int 62:101–105PubMed

16.

Gotz ME, Freyberger A, Riederer P (1990) Oxidative stress: a role in the pathogenesis of Parkinson’s disease. J Neural Transm Suppl 29:241–249PubMed

17.

Jellinger KA, Setinek U, Drlicek M, Bohm G, Steurer A, Lintner F (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213–220CrossRefPubMed

18.

Kibayashi K, Mastri A, Hirsch C (1996) Neuropathology of human immunodeficiency virus infection at different disease stages. Hum Pathol 27:637–642

19.

Kieburtz K, Epstein L, Gelbard H, Greenamyre T (1991) Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex: therapeutic implications. Arch Neurol 48:1281–1284PubMed

20.

Koutsilieri E, Gotz ME, Sopper S, Sauer U, Demuth M, Meulen V ter, Riederer P (1997) Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. J NeuroVirol 3:342–349PubMed

21.

Koutsilieri E, Sopper S, Scheller C, Meulen V ter, Riederer P (2002) Involvement of dopamine in the progression of AIDS dementia complex. J Neural Transm 109:399–410CrossRefPubMed

22.

Koutsilieri E, Sopper S, Scheller C, Meulen V ter, Riederer P (2002) Parkinsonism in HIV dementia. J Neural Transm 109:767–775CrossRefPubMed

23.

Koutsilieri E, Sopper S, Scheller C, Meulen V ter, Riederer P (2002) Dopamine is a pathogenic factor in HIV-induced neuro-AIDS. In: Nagatsu T, Nabeshima R, McCarthy R, Goldstein D (eds) Catecholamine research: from molecular insights to clinical medicine. Kluwer Academic/Plenum, pp 475–478

24.

Lipton SA (1997) Neuropathogenesis of acquired immunodeficiency syndrome dementia. Curr Opin Neurol 10:247–253PubMed

25.

Martinez A, Sell M, Mitrovics T, Stoltenburg-Didinger G, Iglesias-Rozas J, Giraldo-Velásques M, Gosztonyi G, Schneider V, Cervós-Navarro J (1995) The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases. Pathol Res Pract 191:427–443PubMed

26.

Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA (1992) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66:285–291PubMed

27.

Mirsattari S, Power C, Nath A (1998) Parkinsonism with HIV infection. Mov Disord 13:684–689PubMed

28.

Olney JW, Farber NB (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13:335–345CrossRefPubMed

29.

Poli G, Kinter A, Justement J, Kehrl J, Bressler P, Stanley S, Fauci A (1990) Tumor necrosis factor a functions in autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87:782–785PubMed

30.

Raghavan R, Cheney PD, Raymond LA, Joag SV, Stephens EB, Adany I, Pinson DM, Li Z, Marcario JK, Jia F, Wang C, Foresman L, Berman NE, Narayan O (1999) Morphological correlates of neurological dysfunction in macaques infected with neurovirulent simian immunodeficiency virus. Neuropathol Appl Neurobiol 25:285–294CrossRefPubMed

31.

Sauermann U, Stahl-Hennig C, Stolte N, Muhl T, Krawczak M, Spring M, Fuchs D, Kaup FJ, Hunsmann G, Sopper S (2000) Homozygosity for a conserved MHC class II DQ-DRB haplotype is associated with rapid disease progression in simian immunodeficiency virus-infected macaques: results from a prospective study. J Infect Dis 182:716–724PubMed

32.

Sawaya B, Rohr O, Aunis D, Schaeffer E (1996) Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells. J Biol Chem 271:23572–23576CrossRefPubMed

33.

Scheller C, Sopper S, Jassoy C, Meulen V ter, Riederer P, Koutsilieri E (2000) Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 107:1483–1489CrossRefPubMed

34.

Shapshak P, Crandall K, Xin K, Goodkin K, Fujimura R, Bradley W, McCoy C, Nagano I, Yoshioka M, Petito C, Sun N, Srivastava A, Weatherby N, Stewart R, Delgado S, Matthews A, Douyon R, Okuda K, Yang J, Zhangl B, Cao X, Shatkovsky S, Fernandez J, Shah S, Perper J (1996) HIV-1 neuropathogenesis and abused drugs: current reviews, problems, and solutions. Adv Exp Med Biol 402:171–186PubMed

35.

Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS (1994) D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA 91:5720–5724PubMed

36.

Solitare GB (1972) Neuropathologic aspects of drug dependency (narcotic addiction). Hum Pathol 3:85–89PubMed

37.

Sopper S, Sauer U, Hemm S, Demuth M, Müller J, Stahl-Hennig C, Hunsmann G, Meulen V ter, Dörries R (1998) Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. J Virol 72:9940–9947PubMed

38.

Sopper S, Sauer U, Muller JG, Stahl-Hennig C, Meulen V ter (2000) Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses 16:689–697CrossRefPubMed

39.

Sopper S, Koutsilieri E, Scheller C, Czub S, Riederer P, Meulen V ter (2002) Macaque animal model for HIV-induced neurological disease. J Neural Transm 109:747–766CrossRefPubMed

40.

Stahl-Hennig C, Voss G, Dittmer U, Coulibaly C, Petry H, Makoschey B, Cranage M, Aubertin A, Luke W, Hunsmann G (1993) Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus. AIDS 7:787–795PubMed

41.

Szabo J, Cowan WM (1984) A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J Comp Neurol 222:265–300PubMed

42.

Tan SV, Guiloff RJ (1998) Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiatry 65:23–28PubMed

43.

Tatton WG, Chalmers-Redman RM (1996) Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology 47:S171–183PubMed

44.

Tipton K, Singer T (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191–1207PubMed

45.

Tomlinson GS, Simmonds P, Busuttil A, Chiswick A, Bell JE (1999) Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol Appl Neurobiol 25:369–379CrossRefPubMed

46.

Villinger F, Brar SS, Mayne A, Chikkala N, Ansari AA (1995) Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol 155:3946–3954PubMed

47.

Wiley C, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann S, Dailey P, Achim C (1998) Distribution of brain HIV load in AIDS. Brain Pathol 8:277–284PubMed

48.

Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortical damage during HIV infection. Ann Neurol 29:651–657

Titel: Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs
verfasst von: S. Czub
M. Czub
E. Koutsilieri
S. Sopper
F. Villinger
J. G. Müller
C. Stahl-Hennig
P. Riederer
V. ter Meulen
G. Gosztonyi
Publikationsdatum: 01.03.2004
Verlag: Springer-Verlag
Erschienen in: Acta Neuropathologica / Ausgabe 3/2004
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-003-0801-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2004

Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas

Regional alteration of synapsin I in the hippocampal formation of Alzheimer’s disease patients

Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft

Glioblastoma cells release factors that disrupt blood-brain barrier features

Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology